Adicet’s Mission is to Deliver Best-in-Class Gamma Delta T Cell Therapies for Patients Fighting Autoimmune Diseases & Cancer
The power of gamma delta T cells
Gamma delta T cells represent a new generation of immune cell therapy
The Promise of Allogeneic Gamma Delta 1 CAR T Cell Therapy
Novel Targeting
Tissue Homing
Best-in-Class Drug Exposure
Available on Demand
Adicet’s novel platform enables us to potentially deliver therapies that are:
Recent News
December 19,
2024
December 18,
2024
Adicet Bio Appoints Julie Maltzman, M.D. as Chief Medical Officer
November 29,
2024
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
